John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$226M |
| 2 |
JPMorgan Chase
JPM
|
+$212M |
| 3 |
TSMC
TSM
|
+$204M |
| 4 |
Occidental Petroleum
OXY
|
+$194M |
| 5 |
Apple
AAPL
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$271M |
| 2 |
Microsoft
MSFT
|
+$267M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$255M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$226M |
| 5 |
Coca-Cola
KO
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.48% |
| 2 | Healthcare | 15.21% |
| 3 | Industrials | 10.23% |
| 4 | Consumer Discretionary | 10.15% |
| 5 | Financials | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Brown-Forman Class B
BF.B
$13.4B
| $9.81M | 0.03% |
146,322
+65,396
| +81% | +$4.35M |
|
602
iShares Russell 1000 Growth ETF
IWF
$124B
| $9.8M | 0.03% |
141,200
-1,303,600
| -90% | -$89M |
|
|
LAZR
603
PUT
DELISTED
Luminar Technologies
LAZR
| $9.76M | 0.03% |
41,647
+31,647
| +316% | +$6.94M |
|
604
Four Corners Property Trust
FCPT
$2.8B
| $9.74M | 0.03% |
360,359
+11,629
| +3% | +$313K |
|
605
Photronics
PLAB
$1.74B
| $9.69M | 0.03% |
571,044
+48,610
| +9% | +$875K |
|
606
PVH
PVH
$3.65B
| $9.68M | 0.03% |
126,331
+124,347
| +6,267% | +$11.5M |
|
607
DexCom
DXCM
$34.8B
| $9.67M | 0.03% |
75,636
-1,363,908
| -95% | -$149M |
|
|
SRRA
608
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $9.61M | 0.03% |
299,960
+247,437
| +471% | +$7.1M |
|
609
Gen Digital
GEN
$17.1B
| $9.57M | 0.03% |
360,983
-1,953,677
| -84% | -$53.7M |
|
610
Prothena Corp
PRTA
$475M
| $9.55M | 0.03% |
261,291
-40,163
| -13% | -$1.45M |
|
611
OR Royalties Inc
OR
$6.76B
| $9.54M | 0.03% |
723,299
+345,293
| +91% | +$4.29M |
|
612
Twist Bioscience
TWST
$8.69B
| $9.48M | 0.03% |
192,086
+149,143
| +347% | +$8.27M |
|
|
ROCC
613
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $9.48M | 0.03% |
274,695
+201,331
| +274% | +$6.58M |
|
614
KE Holdings
BEKE
$19.9B
| $9.47M | 0.03% |
+765,919
| New | +$13.6M |
|
615
Algonquin Power & Utilities
AQN
$4.37B
| $9.47M | 0.03% |
610,221
+486,100
| +392% | +$7.01M |
|
|
HOUS
616
DELISTED
Anywhere Real Estate
HOUS
| $9.46M | 0.03% |
603,360
-87,920
| -13% | -$1.47M |
|
|
LSXMK
617
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $9.42M | 0.03% |
266,047
+190,487
| +252% | +$7.07M |
|
|
PLYM
618
DELISTED
Plymouth Industrial REIT
PLYM
| $9.41M | 0.03% |
347,258
-66,556
| -16% | -$1.83M |
|
619
PUT
ATI
ATI
$27.9B
| $9.39M | 0.03% |
350,000
+50,000
| +17% | +$1.16M |
|
620
Credit Acceptance
CACC
$6.27B
| $9.35M | 0.03% |
16,994
-50,174
| -75% | -$27.3M |
|
621
Pan American Silver
PAAS
$21.7B
| $9.3M | 0.03% |
340,823
-331,082
| -49% | -$8.15M |
|
622
Virtu Financial
VIRT
$5.79B
| $9.27M | 0.03% |
248,991
+103,544
| +71% | +$3.42M |
|
623
Knowles
KN
$2.81B
| $9.21M | 0.03% |
427,893
+81,037
| +23% | +$1.77M |
|
|
POSH
624
DELISTED
Poshmark, Inc. Class A Common Stock
POSH
| $9.21M | 0.03% |
727,405
-81,645
| -10% | -$1.18M |
|
|
KYNB
625
Kyntra Bio
KYNB
$31.2M
| $9.2M | 0.03% |
30,622
-10,546
| -26% | -$3.68M |
|
Similar funds
John Overdeck's Q1 2022 Portfolio in Review
As of Q1 2022, John Overdeck held 4,846 positions worth $33.9B, down 28% from $46.8B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
John Overdeck withdrew a net $11.3B in Q1 2022, closing 2,304 positions and reducing 976 holdings. Its most notable exit was Pfizer, an estimated $271M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, John Overdeck opened a new position in Cisco worth $223M.
- John Overdeck's largest Q1 2022 buy was Cisco: 4,001,362 shares worth $223M.
- John Overdeck added most to JPMorgan Chase in Q1 2022, an estimated $212M increase.
- John Overdeck's biggest Q1 2022 reduction was Coca-Cola, cutting an estimated $225M.
- John Overdeck fully exited Pfizer in Q1 2022, selling an estimated $271M.
- John Overdeck's ten largest holdings make up 7.2% of its $33.9B portfolio in Q1 2022.
- John Overdeck opened 656 new positions and closed 2,304 in Q1 2022.
- John Overdeck's portfolio value fell 28% quarter-over-quarter to $33.9B.
Based on Two Sigma Investments's 13F filing for Q1 2022, filed 16 May 2022.